Investing Across the Spectrum of Health Care
Working Towards Better, Faster & Less Expensive Health Care.
Great Point Partners brings its sector expertise to two separate but complementary strategies – lower middle market growth buyout funds investing in private health care companies and a hedge fund investing in public life sciences companies.
By the Numbers
$1.7 B
In Private and Public Equity AUM
100+
years of industry experience
30+
industry professionals
CEO & Medical
advisory boards
Funding Transformational Health Care Companies
Great Point Partners Private Equity seeks to invest in growing, profitable health care companies that are led by management teams focused on achieving accelerated and sustainable growth.
Great Point Partners serves as an experienced investor and partner to management teams who share our objectives. Companies choose to work with Great Point Partners because of our health care expertise, our industry contacts and our focus on helping strong management teams grow their businesses.
Supporting Innovation in Drug Development
The BioMedical Value Fund (“BMVF”) seeks to invest in small and mid-capitalization, publicly traded biotechnology and life sciences companies with great technology that will dramatically improve how diseases are treated and managed.
The BMVF team of MDs, PhDs and PharmDs employs a deep value, fundamentally focused investment approach, leveraging a proprietary research team with deep financial and scientific expertise and strives to identify asymmetric risk reward dynamics within the universe of publicly traded life sciences companies.